← back to search

Carlo Wilke

Rehaklinik Zihlschlacht ·
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Genetic Neurodegenerative Diseases, Alzheimer's disease research and treatments, and Dementia and Cognitive Impairment Research.
h-index
38
citations
4,168
works
127
NIH funding
primary concept
email

Recent publications

Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing
Nature Communications 2025cited by 13position: middledoi
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Nature Medicine 2024cited by 180position: middledoi
GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort
EBioMedicine 2024cited by 58position: middledoi
GAA-<i>FGF14</i> ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response
Brain 2023cited by 110position: firstdoi
Standards of NGS Data Sharing and Analysis in Ataxias: Recommendations by the NGS Working Group of the Ataxia Global Initiative
The Cerebellum 2023cited by 12position: middledoi
Plasma extracellular vesicle Tau isoform ratios and TDP-43 inform about molecular pathology in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
Research Square 2023cited by 4position: middledoi
Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
New England Journal of Medicine 2022cited by 236position: middledoi
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog
Alzheimer s Research & Therapy 2022cited by 15position: middledoi
Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
European Journal of Human Genetics 2021cited by 102position: middledoi
Characterizing the Clinical Features and Atrophy Patterns of <i>MAPT</i> -Related Frontotemporal Dementia With Disease Progression Modeling
Neurology 2021cited by 63position: middledoi
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia
Brain 2021cited by 61position: middledoi
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum <scp>NfL</scp> and <scp>pNfH</scp>: A Longitudinal Multicentre Study
Annals of Neurology 2021cited by 43position: firstdoi
Solving unsolved rare neurological diseases—a Solve-RD viewpoint
European Journal of Human Genetics 2021cited by 14position: middledoi
Serum NfL in spinocerebellar ataxia type 1 is increased already at the preataxic stage, correlating with proximity to clinical onset
medRxiv 2021cited by 1position: firstdoi
Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
European Journal of Human Genetics 2021cited by 1position: middledoi
Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint
European Journal of Human Genetics 2021cited by 0position: middledoi
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort
Cortex 2020cited by 49position: middledoi
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
The Lancet Neurology 2019cited by 303position: middledoi
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
The Lancet Neurology 2019cited by 185position: middledoi
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
Acta Neuropathologica 2019cited by 128position: middledoi
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study
NeuroImage Clinical 2019cited by 46position: middledoi
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
The Lancet Neurology 2018cited by 127position: middledoi
Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes
Neurobiology of Aging 2017cited by 38position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Matthis Synofzik · University of Antwerp4 papers (2017–2024)Lüdger Schöls · German Center for Neurodegenerative Diseases2 papers (2021–2023)Rebecca Schüle · Heidelberg University2 papers (2017–2021) · 2 papers (2021–2023)Marie-Josée Dicaire · Montreal Neurological Institute and Hospital2 papers (2023–2024)Bernard Brais · McGill University Health Centre2 papers (2023–2024)Stephan Züchner · University of Miami2 papers (2017–2024)Matt C. Danzi · University of Miami2 papers (2023–2024)David Pellerin · Université de Sherbrooke2 papers (2023–2024)David Mengel · University of Tübingen2 papers (2021–2023)Andreas Traschütz · University of Tübingen2 papers (2023–2024)Jonathan Baets · KU Leuven1 papers (2017–2017)Henry Houlden · University College London Hospitals NHS Foundation Trust1 papers (2023–2023)Jan De Bleecker · Ghent University Hospital1 papers (2017–2017)Stefanie N. Hayer · University of Tübingen1 papers (2017–2017)Maria Rakowicz · Max Delbrück Center1 papers (2021–2021) · 1 papers (2023–2023)Manuela Neumann · German Center for Neurodegenerative Diseases1 papers (2023–2023)Catherine Ashton · McGill University1 papers (2024–2024)Peter De Jonghe · University of Antwerp1 papers (2017–2017)